Logo image of LNZA

LANZATECH GLOBAL INC (LNZA) Stock Fundamental Analysis

NASDAQ:LNZA - Nasdaq - US51655R1014 - Common Stock - Currency: USD

0.22  -0.02 (-8.33%)

Premarket: 0.215 -0.01 (-2.27%)

Fundamental Rating

2

Taking everything into account, LNZA scores 2 out of 10 in our fundamental rating. LNZA was compared to 83 industry peers in the Commercial Services & Supplies industry. While LNZA seems to be doing ok healthwise, there are quite some concerns on its profitability. LNZA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LNZA had negative earnings in the past year.
In the past year LNZA has reported a negative cash flow from operations.
LNZA had negative earnings in 4 of the past 5 years.
In the past 5 years LNZA always reported negative operating cash flow.
LNZA Yearly Net Income VS EBIT VS OCF VS FCFLNZA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

LNZA's Return On Assets of -78.85% is on the low side compared to the rest of the industry. LNZA is outperformed by 90.36% of its industry peers.
LNZA's Return On Equity of -1024.25% is on the low side compared to the rest of the industry. LNZA is outperformed by 87.95% of its industry peers.
Industry RankSector Rank
ROA -78.85%
ROE -1024.25%
ROIC N/A
ROA(3y)-45.65%
ROA(5y)N/A
ROE(3y)-381.98%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LNZA Yearly ROA, ROE, ROICLNZA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

LNZA has a better Gross Margin (47.63%) than 85.54% of its industry peers.
LNZA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LNZA Yearly Profit, Operating, Gross MarginsLNZA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

4

2. Health

2.1 Basic Checks

LNZA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LNZA has been reduced compared to 1 year ago.
The debt/assets ratio for LNZA is higher compared to a year ago.
LNZA Yearly Shares OutstandingLNZA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
LNZA Yearly Total Debt VS Total AssetsLNZA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -8.91, we must say that LNZA is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -8.91, LNZA is not doing good in the industry: 89.16% of the companies in the same industry are doing better.
A Debt/Equity ratio of 3.80 is on the high side and indicates that LNZA has dependencies on debt financing.
The Debt to Equity ratio of LNZA (3.80) is worse than 83.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.8
Debt/FCF N/A
Altman-Z -8.91
ROIC/WACCN/A
WACC7.68%
LNZA Yearly LT Debt VS Equity VS FCFLNZA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M -50M 100M -100M

2.3 Liquidity

A Current Ratio of 3.26 indicates that LNZA has no problem at all paying its short term obligations.
LNZA's Current ratio of 3.26 is amongst the best of the industry. LNZA outperforms 84.34% of its industry peers.
LNZA has a Quick Ratio of 3.07. This indicates that LNZA is financially healthy and has no problem in meeting its short term obligations.
LNZA's Quick ratio of 3.07 is amongst the best of the industry. LNZA outperforms 87.95% of its industry peers.
Industry RankSector Rank
Current Ratio 3.26
Quick Ratio 3.07
LNZA Yearly Current Assets VS Current LiabilitesLNZA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for LNZA have decreased strongly by -12.90% in the last year.
Looking at the last year, LNZA shows a very negative growth in Revenue. The Revenue has decreased by -20.82% in the last year.
EPS 1Y (TTM)-12.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.08%
Revenue 1Y (TTM)-20.82%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-7.46%

3.2 Future

LNZA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.64% yearly.
LNZA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.28% yearly.
EPS Next Y34.31%
EPS Next 2Y20.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year48.73%
Revenue Next 2Y18.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

LNZA Yearly Revenue VS EstimatesLNZA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 20M 40M 60M 80M
LNZA Yearly EPS VS EstimatesLNZA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

LNZA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LNZA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LNZA Price Earnings VS Forward Price EarningsLNZA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LNZA Per share dataLNZA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as LNZA's earnings are expected to grow with 20.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.64%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LNZA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LANZATECH GLOBAL INC

NASDAQ:LNZA (5/21/2025, 8:13:11 PM)

Premarket: 0.215 -0.01 (-2.27%)

0.22

-0.02 (-8.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-19 2025-05-19/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners63.64%
Inst Owner Change-2.35%
Ins Owners2.12%
Ins Owner Change0%
Market Cap43.54M
Analysts78
Price Target2.04 (827.27%)
Short Float %5.29%
Short Ratio3.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.73%
Min EPS beat(2)-49.87%
Max EPS beat(2)-3.59%
EPS beat(4)0
Avg EPS beat(4)-18.49%
Min EPS beat(4)-49.87%
Max EPS beat(4)-1.15%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-47.8%
Min Revenue beat(2)-49.94%
Max Revenue beat(2)-45.67%
Revenue beat(4)1
Avg Revenue beat(4)-21.41%
Min Revenue beat(4)-49.94%
Max Revenue beat(4)20.73%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-23.81%
PT rev (3m)-38.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.51%
EPS NY rev (1m)-6.37%
EPS NY rev (3m)3.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.92%
Revenue NY rev (1m)-16.09%
Revenue NY rev (3m)-22.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.88
P/FCF N/A
P/OCF N/A
P/B 3.24
P/tB 3.24
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS0.25
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -78.85%
ROE -1024.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.63%
FCFM N/A
ROA(3y)-45.65%
ROA(5y)N/A
ROE(3y)-381.98%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 3.8
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 94.99%
Cap/Sales 10.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.26
Quick Ratio 3.07
Altman-Z -8.91
F-Score3
WACC7.68%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.08%
EPS Next Y34.31%
EPS Next 2Y20.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.82%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-7.46%
Revenue Next Year48.73%
Revenue Next 2Y18.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.46%
OCF growth 3YN/A
OCF growth 5YN/A